BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 24704219)

  • 1. Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis.
    Upthegrove R; Manzanares-Teson N; Barnes NM
    Schizophr Res; 2014 May; 155(1-3):101-8. PubMed ID: 24704219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation in first-episode psychosis: The contribution of inflammatory biomarkers to the emergence of negative symptoms, a systematic review and meta-analysis.
    Dunleavy C; Elsworthy RJ; Upthegrove R; Wood SJ; Aldred S
    Acta Psychiatr Scand; 2022 Jul; 146(1):6-20. PubMed ID: 35202480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of risperidone on cytokine profile in drug-naïve first-episode psychosis.
    Noto C; Ota VK; Gouvea ES; Rizzo LB; Spindola LM; Honda PH; Cordeiro Q; Belangero SI; Bressan RA; Gadelha A; Maes M; Brietzke E
    Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25522386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute variations of cytokine levels after antipsychotic treatment in drug-naïve subjects with a first-episode psychosis: A meta-analysis.
    Capuzzi E; Bartoli F; Crocamo C; Clerici M; Carrà G
    Neurosci Biobehav Rev; 2017 Jun; 77():122-128. PubMed ID: 28285148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression, Cytokine, and Cytokine by Treatment Interactions Modulate Gene Expression in Antipsychotic Naïve First Episode Psychosis.
    Noto C; Ota VK; Santoro ML; Gouvea ES; Silva PN; Spindola LM; Cordeiro Q; Bressan RA; Gadelha A; Brietzke E; Belangero SI; Maes M
    Mol Neurobiol; 2016 Oct; 53(8):5701-9. PubMed ID: 26491028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects.
    Miller BJ; Buckley P; Seabolt W; Mellor A; Kirkpatrick B
    Biol Psychiatry; 2011 Oct; 70(7):663-71. PubMed ID: 21641581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic treatment reduces psychotic symptoms and markers of low-grade inflammation in first episode psychosis patients, but increases their body mass index.
    Haring L; Koido K; Vasar V; Leping V; Zilmer K; Zilmer M; Vasar E
    Schizophr Res; 2015 Dec; 169(1-3):22-29. PubMed ID: 26364730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first episode psychosis.
    Noto MN; Maes M; Nunes SOV; Ota VK; Rossaneis AC; Verri WA; Cordeiro Q; Belangero SI; Gadelha A; Bressan RA; Noto C
    Eur Neuropsychopharmacol; 2019 Mar; 29(3):416-431. PubMed ID: 30594344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immuno-inflammatory changes across phases of early psychosis: The impact of antipsychotic medication and stage of illness.
    Kelsven S; de la Fuente-Sandoval C; Achim CL; Reyes-Madrigal F; Mirzakhanian H; Domingues I; Cadenhead K
    Schizophr Res; 2020 Dec; 226():13-23. PubMed ID: 32089474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the anti-inflammatory effect of aripiprazole and risperidone in 75 drug-naïve first episode psychosis individuals: A 3 months randomized study.
    Juncal-Ruiz M; Riesco-Dávila L; Ortiz-García de la Foz V; Martínez-Garcia O; Ramírez-Bonilla M; Ocejo-Viñals JG; Leza JC; López-Hoyos M; Crespo-Facorro B
    Schizophr Res; 2018 Dec; 202():226-233. PubMed ID: 29941296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the cytokine profile in first-episode, drug-naïve patients with psychosis after short-term antipsychotic treatment.
    Petrikis P; Voulgari PV; Tzallas AT; Boumba VA; Archimandriti DT; Zambetas D; Papadopoulos I; Tsoulos I; Skapinakis P; Mavreas V
    Psychiatry Res; 2017 Oct; 256():378-383. PubMed ID: 28688350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evidence map of interventions across premorbid, ultra-high risk and first episode phases of psychosis.
    Liu P; Parker AG; Hetrick SE; Callahan P; de Silva S; Purcell R
    Schizophr Res; 2010 Oct; 123(1):37-44. PubMed ID: 20558043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse.
    Borovcanin M; Jovanovic I; Radosavljevic G; Djukic Dejanovic S; Bankovic D; Arsenijevic N; Lukic ML
    J Psychiatr Res; 2012 Nov; 46(11):1421-6. PubMed ID: 22974591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine profile in first-episode psychosis, unaffected siblings and community-based controls: the effects of familial liability and childhood maltreatment.
    Corsi-Zuelli F; Loureiro CM; Shuhama R; Fachim HA; Menezes PR; Louzada-Junior P; Mondelli V; Del-Ben CM
    Psychol Med; 2020 May; 50(7):1139-1147. PubMed ID: 31064423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis.
    Mondelli V; Ciufolini S; Belvederi Murri M; Bonaccorso S; Di Forti M; Giordano A; Marques TR; Zunszain PA; Morgan C; Murray RM; Pariante CM; Dazzan P
    Schizophr Bull; 2015 Sep; 41(5):1162-70. PubMed ID: 25829375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
    Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
    Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early interventions in a US military FIRST episode psychosis program.
    Hann MC; Caporaso E; Loeffler G; Cuellar A; Herrington L; Marrone L; Yoon J
    Early Interv Psychiatry; 2018 Dec; 12(6):1243-1249. PubMed ID: 29971958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active psychosis and pro-inflammatory cytokines in first-episode of psychosis.
    Pardo-de-Santayana G; Juncal-Ruiz M; Vázquez-Bourgon J; Riesco-Dávila L; Ortiz-Garcia de la Foz V; Pelayo-Terán JM; López-Hoyos M; Crespo-Facorro B
    J Psychiatr Res; 2021 Feb; 134():150-157. PubMed ID: 33385633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention.
    Francey SM; Nelson B; Thompson A; Parker AG; Kerr M; Macneil C; Fraser R; Hughes F; Crisp K; Harrigan S; Wood SJ; Berk M; McGorry PD
    Schizophr Res; 2010 Jun; 119(1-3):1-10. PubMed ID: 20347270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.